Abstract
Background: Reperfusion injury remains a significant risk factor in the immediate postoperative course after lung transplantation. We report on our initial clinical experience of surfactant replacement in reperfusion injury after clinical lung transplantation. Methods and results: In 31 consecutive patients, lung (8 single lung, 16 bilateral lung) or heart-lung (7) transplantation was performed. In 6 patients, severe reperfusion injury developed and was treated with continuously nebulized surfactant. Compliance of the allograft increased 40 ± 25 % within 3 h following treatment with surfactant. Alveolar arterial oxygen gradient decreased by 23 ± 11 % after 3 h and by 35 ± 20 % after 6 h. Normal graft function was reestablished within 1–3 days after transplantation. All treated recipients were extubated until the 6th postoperative day. The 30-day mortality for the 31 recipients was 3.3 %, the 1-year survival 84 %. Conclusions: Surfactant replacement may become a clinical method for treatment of reperfusion injury after lung transplantation.
Article PDF
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Final revision received: 14 April 1999 Accepted: 23 April 1999
Rights and permissions
About this article
Cite this article
Strüber, M., Hirt, S., Cremer, J. et al. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25, 862–864 (1999). https://doi.org/10.1007/s001340050967
Issue Date:
DOI: https://doi.org/10.1007/s001340050967